Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of healthcare inequalities in kidney disease on NHS waiting lists.

The Government is committed to building a fairer Britain by tackling the structural inequalities that contribute to poor health, particularly for disadvantaged groups. We are dedicated to ensuring that people live well for longer and spend less time in ill health, regardless of where they are born or their financial circumstances.

Our Health Mission in England will focus on addressing the social determinants of health, with the goal of halving the gap in healthy life expectancy between the richest and poorest regions. We will work across Government to address the root causes of health inequalities, including barriers of access to health and care services. We will prioritise prevention, shift more care into the community, and intervene earlier in life to raise the healthiest generation of children in our history.

The 10-Year Health Plan will ensure a better health service for everyone, regardless of condition or service area. On 21 October 2024, we launched a national conversation on the future of the National Health Service, inviting views from across the country on how to deliver a health service fit for the future. Patients, staff, and organisations, including those with experience of, or expertise in, kidney disease, can make themselves heard by logging onto the online portal, which is available at the following link:

http://change.nhs.uk

No formal assessment has been made of the potential impact of healthcare inequalities in kidney disease on NHS waiting lists.

We recognise that patients have been let down for too long whilst they wait for the care they need, including for kidney disease. Currently, the overall waiting list stands at 7.64 million patient pathways, with over six million people waiting. The Government is committed to putting patients first. This means making sure that patients are seen on time and ensuring that people have the best possible experience during their care.

Today, fewer than 60% of patients are being seen within 18 weeks. We will ensure 92% of patients return to waiting no longer than 18 weeks from Referral to Treatment within our first term, a standard which has not been met consistently since September 2015.

Tackling waiting lists is a key part of our Health Mission. We will start by delivering an extra 40,000 operations, scans, and appointments each week, as the first step in our commitment to ensuring patients are treated within 18 weeks. We will also address the challenges in diagnostic waiting times, providing the number of computed tomography, magnetic resonance imaging, and other tests that are needed to reduce elective waits.

NHS England has established the Renal Services Transformation Programme (RSTP), which aims to reduce unwarranted variation in the quality and accessibility of renal care, to improve outcomes and services for those with kidney disease. NHS England, through the RSTP and regional renal clinical networks, is implementing initiatives to provide better, integrated care, to reduce health inequalities, and to focus on prevention and timely intervention for kidney disease.

Working in collaboration with the NHS RightCare Programme and the renal community, the RSTP has developed a renal toolkit to provide integrated care boards, regional renal clinical networks, and providers with tools, case studies, and principles to support the transformation of services at a local level. The toolkit outlines principles to support better management of patients identified with chronic kidney disease (CKD) throughout their patient journey. The RSTP is working closely with NHS England’s regional renal clinical networks to review this toolkit, to work with local partners to develop transformation programmes that will focus on the early identification and management of kidney disease, and which will seek to reduce the number of patients progressing through the various stages of CKD and reduce the number of patients requiring dialysis. By supporting prevention and early intervention, the need for late-stage treatments will be reduced.